Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26


EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteins.

Fitzsimmons L, Cartlidge R, Chang C, Sejic N, Galbraith LCA, Suraweera CD, Croom-Carter D, Dewson G, Tierney RJ, Bell AI, Shannon-Lowe C, Herold MJ, Rickinson AB, Colman PM, Huang DCS, Strasser A, Kvansakul M, Rowe M, Kelly GL.

Cell Death Differ. 2019 Oct 23. doi: 10.1038/s41418-019-0435-1. [Epub ahead of print]


Coordinated repression of BIM and PUMA by Epstein-Barr virus latent genes maintains the survival of Burkitt lymphoma cells.

Fitzsimmons L, Boyce AJ, Wei W, Chang C, Croom-Carter D, Tierney RJ, Herold MJ, Bell AI, Strasser A, Kelly GL, Rowe M.

Cell Death Differ. 2018 Feb;25(2):241-254. doi: 10.1038/cdd.2017.150. Epub 2017 Sep 29.


Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination.

Brooks JM, Long HM, Tierney RJ, Shannon-Lowe C, Leese AM, Fitzpatrick M, Taylor GS, Rickinson AB.

PLoS Pathog. 2016 Apr 20;12(4):e1005549. doi: 10.1371/journal.ppat.1005549. eCollection 2016 Apr.


The Epstein-Barr virus BamHI C promoter is not essential for B cell immortalization in vitro, but it greatly enhances B cell growth transformation.

Tierney RJ, Nagra J, Rowe M, Bell AI, Rickinson AB.

J Virol. 2015 Mar;89(5):2483-93. doi: 10.1128/JVI.03300-14. Epub 2014 Dec 24.


Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA.

Tierney RJ, Shannon-Lowe CD, Fitzsimmons L, Bell AI, Rowe M.

Virology. 2015 Jan 1;474:117-30. doi: 10.1016/j.virol.2014.10.030. Epub 2014 Nov 15.


Cooperation between Epstein-Barr virus immune evasion proteins spreads protection from CD8+ T cell recognition across all three phases of the lytic cycle.

Quinn LL, Zuo J, Abbott RJ, Shannon-Lowe C, Tierney RJ, Hislop AD, Rowe M.

PLoS Pathog. 2014 Aug 21;10(8):e1004322. doi: 10.1371/journal.ppat.1004322. eCollection 2014 Aug.


Repression of the proapoptotic cellular BIK/NBK gene by Epstein-Barr virus antagonizes transforming growth factor β1-induced B-cell apoptosis.

Campion EM, Hakimjavadi R, Loughran ST, Phelan S, Smith SM, D'Souza BN, Tierney RJ, Bell AI, Cahill PA, Walls D.

J Virol. 2014 May;88(9):5001-13. doi: 10.1128/JVI.03642-13. Epub 2014 Feb 19.


Epstein-Barr virus latent gene sequences as geographical markers of viral origin: unique EBNA3 gene signatures identify Japanese viruses as distinct members of the Asian virus family.

Sawada A, Croom-Carter D, Kondo O, Yasui M, Koyama-Sato M, Inoue M, Kawa K, Rickinson AB, Tierney RJ.

J Gen Virol. 2011 May;92(Pt 5):1032-43. doi: 10.1099/vir.0.030023-0. Epub 2011 Jan 19.


Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.

Hutchings IA, Tierney RJ, Kelly GL, Stylianou J, Rickinson AB, Bell AI.

J Virol. 2006 Nov;80(21):10700-11. Epub 2006 Aug 18.


Multiple Epstein-Barr virus strains in patients with infectious mononucleosis: comparison of ex vivo samples with in vitro isolates by use of heteroduplex tracking assays.

Tierney RJ, Edwards RH, Sitki-Green D, Croom-Carter D, Roy S, Yao QY, Raab-Traub N, Rickinson AB.

J Infect Dis. 2006 Jan 15;193(2):287-97. Epub 2005 Dec 14.


Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.

Kelly GL, Milner AE, Tierney RJ, Croom-Carter DS, Altmann M, Hammerschmidt W, Bell AI, Rickinson AB.

J Virol. 2005 Aug;79(16):10709-17.


Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains.

Brooks JM, Croom-Carter DS, Leese AM, Tierney RJ, Habeshaw G, Rickinson AB.

J Virol. 2000 Feb;74(4):1801-9.


Epidemiology of infection with Epstein-Barr virus types 1 and 2: lessons from the study of a T-cell-immunocompromised hemophilic cohort.

Yao QY, Croom-Carter DS, Tierney RJ, Habeshaw G, Wilde JT, Hill FG, Conlon C, Rickinson AB.

J Virol. 1998 May;72(5):4352-63.


Conserved CTL epitopes within EBV latent membrane protein 2: a potential target for CTL-based tumor therapy.

Lee SP, Tierney RJ, Thomas WA, Brooks JM, Rickinson AB.

J Immunol. 1997 Apr 1;158(7):3325-34.


Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals.

Yao QY, Tierney RJ, Croom-Carter D, Cooper GM, Ellis CJ, Rowe M, Rickinson AB.

J Virol. 1996 Aug;70(8):4895-903.


Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals.

Yao QY, Tierney RJ, Croom-Carter D, Dukers D, Cooper GM, Ellis CJ, Rowe M, Rickinson AB.

J Virol. 1996 Aug;70(8):4884-94.


PCR for the detection of cervical HPV16 infection: the need for standardization.

Tierney RJ, Ellis JR, Winter H, Kaur S, Wilson S, Woodman CB, Young LS.

Int J Cancer. 1993 Jun 19;54(4):700-1. No abstract available.


PCR for the detection of genital human papillomavirus infection: a mixed blessing.

Young LS, Tierney RJ, Ellis JR, Winter H, Woodman CB.

Ann Med. 1992 Jun;24(3):215-9. Review. No abstract available.


Inferential reading abilities of mildly mentally retarded and nonretarded students.

Bos CS, Tierney RJ.

Am J Ment Defic. 1984 Jul;89(1):75-82.


Rheumatology corner: scleroderma.

Tierney RJ.

Minn Med. 1981 Aug;64(8):475-6. No abstract available.


Medico-legal management of the juvenile kidney donor.

Santiago-Delpín EA, Simmons RL, Simmons RG, Tierney RJ, Bernstein D, Kjellstrand CM, Buselmeier TJ, Najarian JS.

Transplant Proc. 1974 Dec;6(4):441-5. No abstract available.


Procurement of transplantable tissues.

Ersek RA, Cutting E, Chou S, Tierney RJ, Najarian JS, Lillehei RC.

Minn Med. 1969 Jan;52(1):183-93. No abstract available.


Supplemental Content

Loading ...
Support Center